Preparation and characterization of ibuprofen/modified chitosan/TiO2 hybrid composite as a controlled drug-delivery system

Microporous and Mesoporous Materials

Volumn 234, Issue , 2016, Pages 361-369

  Kamari, Younes ^a   Ghiaci, Mehran ^a  

^a ISFAHAN UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Controlled drug delivery; Hybrid composite; Ibuprofen; Modified chitosan; Porous coating

Indexed keywords

CHITIN; CHITOSAN; COATINGS; DRUG PRODUCTS; HYBRID MATERIALS; TITANIUM DIOXIDE;

ANTI-INFLAMMATORY DRUGS; CONTROLLED DRUG DELIVERY SYSTEMS; DIETHYLENETRIAMINE; HYBRID COMPOSITES; IBUPROFEN; MODIFIED CHITOSAN; POROUS COATINGS; ZETA POTENTIAL ANALYSIS;

CONTROLLED DRUG DELIVERY;

EID: 84980329981     PISSN: 13871811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micromeso.2016.07.030     Document Type: Article

References (58)

1. [1] Lee, J.H., Yeo, Y., Controlled drug release from pharmaceutical nanocarriers. Chem. Eng. Sci. 125 (2015), 75–84.
2. [2] Frima, H.J., Gabellieri, C., Nilsson, M.I., Drug delivery research in the european Union's Seventh Framework Programme for Research. J. Control. Release 161 (2012), 409–415.
3. [3] Yang, P., Quan, Z., Lu, L., Huang, S., Lin, J., Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems. Biomaterials 29 (2008), 692–702.
4. [4] Qu, F., Zhu, G., Lin, H., Zhang, W., Sun, J., Li, S., Qiu, S., A controlled release of ibuprofen by systematically tailoring the morphology of mesoporous silica materials. J. Solid State Chem. 179 (2006), 2027–2035.
5. [5] Narang, N., An updated review on: floating drug delivery system (FDDS). Int. J. Appl. Pharm. 3 (2011), 1–7.
6. [6] Qiu, X., Leporatti, S., Donath, E., Möhwald, H., Studies on the drug release properties of polysaccharide multilayers encapsulated ibuprofen microparticles. Langmuir 17 (2001), 5375–5380.
7. [7] Langer, R.S., Peppas, N.A., Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 2 (1981), 201–214.
8. [8] Bushra, R., Aslam, N., An overview of clinical pharmacology of Ibuprofen. Oman Med. J. 25 (2010), 155–222.
9. [9] Dalton, J.D., Schweinle, J.E., Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Ann. Emerg. Med. 48 (2006), 615–623.
10. [10] Ofokansi, K.C., Kenechukwu, F.C., Isah, A.B., Okigbo, E.L., Formulation and evaluation of glutaraldehyde-crosslinked chitosan microparticles for the delivery of ibuprofen. Trop. J. Pharm. Res. 12 (2013), 19–25.
11. [11] Myers, R.L., 100 Most Important Chemical Compounds: a Reference Guide. 2007, Greemwood Press, London, 150–152.
12. [12] Almeida, H., Amaral, M.H., Lobão, P., Comparative study of sustained-release lipid microparticles and solid dispersions containing ibuprofen. Braz. J. Pharm. Sci. 48 (2012), 529–536.
13. [13] Hwang, S.J., Rhee, G.J., Lee, K.M., Oh, K.H., Kim, C.K., Release characteristics of ibuprofen from excipient-loaded alginate gel beads. Int. J. Pharm. 116 (1995), 125–128.
14. [14] Devrim, B., Canefe, K., Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (eudragit) by quasi emulsion solvent diffusion method: effect of variables. Acta Pol. Pharm. Drug Res. 63 (2006), 521–524.
15. [15] Alias, S.S., Chee, S.M., Mohamad, A.A., Chitosan–ammonium acetate–ethylene carbonate membrane for proton batteries. Arab. J. Chem., 2014, 10.1016/j.arabjc.2014.05.001.
16. [16] Liu, Y., Yan, K., Jiang, G., Xiong, Y., Du, Y., Shi, X., Electrical signal guided ibuprofen release from electrodeposited chitosan hydrogel. Int. J. Polym. Sci., 2014 doi.org/10.1155/2014/736898.
17. [17] Wang, Q., Preparation and performance testing of chitosan-ibuprofen sustained release microspheres. Adv. Mater. Res. 311 (2011), 377–381.
18. [18] Abdeen, R., Salahuddin, N., Modified chitosan-clay nanocomposite as a drug delivery system intercalation and in vitro release of ibuprofen. J. Chem., 2013 doi.org/10.1155/2013/576370.
19. [19] Vieira, A.P., Badshah, S., Airoldi, C., Ibuprofen-loaded chitosan and chemically modified chitosans—Release features from tablet and film forms. Int. J. Biol. Macromol. 52 (2013), 107–115.
20. [20] Lu, Z., Steenekamp, J.H., Hamman, J.H., Cross-linked cationic polymer microparticles: effect of N-trimethyl chitosan chloride on the release and permeation of ibuprofen. Drug Dev. Ind. Pharm. 31 (2005), 311–317.
21. [21] Ghiaci, M., Dorostkar, N., Martínez-Huerta, M.V., Fierro, J.L.G., Moshiri, P., Synthesis and characterization of gold nanoparticles supported on thiol functionalized chitosan for solvent-free oxidation of cyclohexene with molecular oxygen. J. Mol. Catal. A Chem. 379 (2013), 340–349.
22. 2+ ions from diluted solutions. Sep. Sci. Technol. 48 (2013), 2140–2149.
23. [23] Pan, Y., Wang, J., Sun, C., Liu, X., Zhang, H., Fabrication of highly hydrophobic organic–inorganic hybrid magnetic polysulfone microcapsules: a lab-scale feasibility study for removal of oil and organic dyes from environmental aqueous samples. J. Hazard. Mater. 309 (2016), 65–76.
24. [24] Sun, L., Liu, T., Li, H., Yang, L., Meng, L., Lu, Q., Long, J., Fluorescent and cross-linked organic–inorganic hybrid nanoshells for monitoring drug delivery. ACS Appl. Mater. Interfaces 7 (2015), 4990–4997.
25. [25] Xu, T., Zhang, J., Chi, H., Cao, F., Multifunctional properties of organic-inorganic hybrid nanocomposites based on chitosan derivatives and layered double hydroxides for ocular drug delivery. Acta Biomater. 36 (2016), 152–163.
26. [26] Zhao, X., Zhao, J., Lin, Z.Y.W., Pan, G., Zhu, Y., Cheng, Y., Cui, W., Self-coated interfacial layer at organic/inorganic phase for temporally controlling dual-drug delivery from electrospun fibers. Colloids Surf. B Biointerfaces 130 (2015), 1–9.
27. [27] Ribeiro, L.N.M., Alcântara, A.C.S., Darder, M., Aranda, P., Araújo-Moreira, F.M., Ruiz-Hitzky, E., Pectin-coated chitosan–LDH bionanocomposite beads as potential systems for colon-targeted drug delivery. Int. J. Pharm. 463 (2014), 1–9.
28. [28] Hua, S., Yang, H., Wang, W., Wang, A., Controlled release of ofloxacin from chitosan–montmorillonite hydrogel. Appl. Clay Sci. 50 (2010), 112–117.
29. [29] Lyndon, J.A., Boyd, B.J., Birbilis, N., Metallic implant drug/device combinations for controlled drug release in orthopaedic applications. J. Control. Release 179 (2014), 63–75.
30. [30] Simchi, A., Tamjid, E., Pishbin, F., Boccaccini, A.R., Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications. Nanomedicine Nanotechnol. Biol. Med. 7 (2011), 22–39.
31. [31] Maroni, A., Del Curto, M.D., Zema, L., Foppoli, A., Gazzaniga, A., Film coatings for oral colon delivery. Int. J. Pharm. 457 (2013), 372–394.
32. [32] Gultepe, E., Nagesha, D., Sridhar, S., Amiji, M., Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices. Adv. Drug Deliv. Rev. 62 (2010), 305–315.
33. [33] Martirosyan, A., Schneider, Y.J., Engineered nanomaterials in food: implications for food safety and consumer health. Int. J. Environ. Res. Public Health 11 (2014), 5720–5750.
34. 2 matrices. Microporous Mesoporous Mater. 139 (2011), 189–196.
35. 2 implants for loading high dosage of antibacterial agent. Appl. Surf. Sci. 303 (2014), 140–146.
36. 2 nanospheres for loading and release of ibuprofen. Powder Technol. 235 (2013), 103–109.
37. [37] Zhi, X., Fang, H., Bao, C., Shen, G., Zhang, J., Wang, K., Guo, S., Wan, T., Cui, D., The immunotoxicity of graphene oxides and the effect of PVP-coating. Biomaterials 34 (2013), 5254–5261.
38. [38] Archana, D., Singh, B.K., Dutta, J., Dutta, P.K., In vivo evaluation of chitosan–PVP–titanium dioxide nanocomposite as wound dressing material. Carbohydr. Polym. 95 (2013), 530–539.
39. [39] Xu, X., Lu, P., Guo, M., Fang, M., Cross-linked gelatin/nanoparticles composite coating on micro-arc oxidation film for corrosion and drug release. Appl. Surf. Sci. 256 (2010), 2367–2371.
40. [40] Yu, H., Xiao, C., Synthesis and properties of novel hydrogels from oxidized konjac glucomannan crosslinked gelatin for in vitro drug delivery. Carbohydr. Polym. 72 (2008), 479–489.
41. [41] Nguyen, S., Alund, S.J., Hiorth, M., Kjøniksen, A.L., Smistad, G., Studies on pectin coating of liposomes for drug delivery. Colloids Surf. B Biointerfaces 88 (2011), 664–673.
42. 2 composites with controlled drug-delivery properties. Appl. Surf. Sci. 342 (2015), 26–33.
43. [43] Brunauer, S., Emmett, P.H., Teller, E., Adsorption of gases in multimolecular layers. J. Am. Chem. Soc. 60 (1938), 309–319.
44. [44] Barrett, E.P., Joyner, L.G., Halenda, P.P., The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. J. Am. Chem. Soc. 73 (1951), 373–380.
45. [45] Ramukutty, S., Ramachandran, E., Growth, spectral and thermal studies of ibuprofen crystals. Cryst. Res. Technol. 47 (2012), 31–38.
46. [46] Ganesh, M., Lee, S.G., Synthesis, characterization and drug release capability of new cost effective mesoporous silica nano particles for ibuprofen drug delivery. Int. J. Cont. Auto. 6 (2013), 207–216.
47. [47] Ordikhani, F., Simchi, A., Long-term antibiotic delivery by chitosan-based composite coatings with bone regenerative potential. Appl. Surf. Sci. 317 (2014), 56–66.
48. [48] Krupa, A., Majda, D., Jachowicz, R., Mozgawa, W., Solid-state interaction of ibuprofen and Neusilin US2. Thermochim. Acta 509 (2010), 12–17.
49. [49] Jana, S., Maji, N., Nayak, A.K., Sen, K.K., Basu, S.K., Development of chitosan-based nanoparticles through inter-polymeric complexation for oral drug delivery. Carbohydr. Polym. 98 (2013), 870–876.
50. [50] Krishnaveni, R., Thambidurai, S., Industrial method of cotton fabric finishing with chitosan–ZnO composite for anti-bacterial and thermal stability. Ind. Crops Prod. 47 (2013), 160–167.
51. [51] Pandis, C., Madeira, S., Matos, J., Kyritsis, A., Mano, J.F., Ribelles, J.L.G., Chitosan–silica hybrid porous membranes. Mater. Sci. Eng. C 42 (2014), 553–561.
52. [52] Greenwood, R., Review of the measurement of zeta potentials in concentrated aqueous suspensions using electroacoustics. Adv. Colloid Interface Sci. 106 (2003), 55–81.
53. [53] Greenwood, R., Kendall, K., Selection of suitable dispersants for aqueous suspensions of zirconia and titania powders using acoustophoresis. J. Eur. Ceram. Soc. 19 (1999), 479–488.
54. [54] Ofokansi, K., Winter, G., Fricker, G., Coester, C., Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery. Eur. J. Pharm. Biopharm. 76 (2010), 1–9.
55. [55] Leofanti, G., Padovan, M., Tozzola, G., Venturelli, B., Surface area and pore texture of catalysts. Catal. Today 41 (1998), 207–219.
56. [56] Sing, K.S.W., Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Recommendations 1984). Pure Appl. Chem. 57 (1985), 603–619.
57. [57] Kruk, M., Jaroniec, M., Gas adsorption characterization of ordered organic-inorganic nanocomposite materials. Chem. Mater. 13 (2001), 3169–3183.
58. [58] Albarran, L., López, T., Quintana, P., Chagoya, V., Controlled release of IFC-305 encapsulated in silica nanoparticles for liver cancer synthesized by sol–gel. Colloids Surf. A Physicochem. Eng. Asp. 384 (2011), 131–136.